IONS - Ionis experimental drug meets key goal in familial chylomicronemia study April, 08 2024 10:16 AM Ionis Pharmaceuticals Inc. 2024-04-08 10:16:48 ET Ionis Pharmaceuticals ( NASDAQ: IONS ) on Sunday announced positive results from a late-stage study of its lead investigational drug, olezarsen.... For further details see: Ionis experimental drug meets key goal in familial chylomicronemia study